WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Transplant Product Efficacy Framework v8, Banff grade is staged as IIB, Estimated GFR (eGFR) accounts for Serum Creatinine (SCr), defined time points including 12 months, Banff grade is staged as IIA, EBV increases risk for PTLD (post-transplant lymphoproliferative disorder), Study Drug has value for Dosage, Glomerular Filtration Rate (GFR) is associated with Cardiovascular (CV) risk, Transplant Donor can be Living-non-related, Transplant Donor have HLA types, Estimated GFR (eGFR) is correlated with Graft Loss, CV death can result from Toxicity, Actual Trough Concentration measured for Study Drug, defined time points including 12 months, Banff grade accounts for C4d status, Transplant Donor provides Organ, Banff grade accounts for Tubulitis, Observation or Assessment is used to monitor the effectiveness of Therapeutic Intervention, Observation or Assessment is used to monitor the state of Physiolgoical Process, Renal function/ Impairment leads to Never Functioning Graft, Biopsy performed for Surveillance (Protocol)